Publications

TitleAbstractYear
Filter
PMID
Filter
antibodies against hepatitis c virus in hemodialysis patients in the central italian region of umbria: evaluation of some risk factors.the epidemiology of non-a, non-b hepatitis (nanbh) is still incomplete. to define the prevalence of antibodies against the main causative agent of nanbh, the hepatitis c virus (hcv) and the role of some risk factors, we tested sera from 269 patients on chronic dialysis at the hemodialysis units in our region in central italy. we utilized the recently developed serological assay. twenty-nine hemodialysis patients (13.3%) and 3 peritoneal dialysis patients (4.8%) were anti-hcv positive. of these, ...19921323768
management of hepatitis b virus reactivation in patients with hematological malignancies treated with chemotherapy.hepatitis b virus (hbv) reactivation is a major cause of morbidity and mortality in patients with hematological malignancies who receive cytotoxic chemotherapy. we have therefore carried out a prospective observational study out to assess the incidence, prevalence, and clinical course ina cohort of these patients.201019904491
Displaying items 1 - 2 of 2